… therapy, new antithrombotics and reperfusion strategies (either pharmacological or … myocardial
infarction; at least some of these adverse events are related to the no reflow phenomenon …

… In a canine model of myocardial ischaemia and reperfusion the no reflow zone which was
delineated by the absence of Thioflavin S, a vital stain for the endothelium, was nearly three …

… observed the no-reflow phenomenon in every animal model of acute myocardial infarction
that … the size of the no-reflow area grows with the duration of reperfusion. In our experimental …

… reperfusion related injury, and individual susceptibility to microvascular injury) are responsible
for no-reflow phenomenon… LV remodeling after acute myocardial infarction, being superior …

… that brought the no-reflow phenomenon to light because it … in human hearts in the setting
of acute myocardial infarction. … of the no-reflow zones over the early hours of reperfusion. …

… without complete myocardial reperfusion despite successful … describes the main
pathophysiological mechanisms of no-reflow, … simple angiographic thrombolysis in myocardial …

… Clinically, myocardial “no-reflow” is used both to refer to microvascular perfusion deficits
after reperfusion therapy for acute myocardial infarction by thrombolysis and/or percutaneous …

… Although sometimes the reperfusion is provided, blood flow cannot be supplied to the
myocardial tissue. This is called a no-reflow phenomenon. A lot of exogenous antioxidant agents …

… -15 protects from ischemia/reperfusion injury and no-reflow, by … generation during myocardial
ischemia and reperfusion. … predicting no-reflow in STelevation myocardial infarction treated …

… can, therefore, occur at the same time and within the same region as no reflow caused by
prolonged ischemia and reperfusion. Clinicians have focused on reversal of these iatrogenic …